Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
International Journal of Traditional Chinese Medicine ; (6): 464-471, 2023.
Artículo en Chino | WPRIM | ID: wpr-989656

RESUMEN

Objective:To analyze the mechanism of Jindan Tablets, Xiaoyan Lidan Tablets and ursodeoxycholic acid in the treatment of gallstone and cholecystitis based on network pharmacology; To conduct a comparative analysis.Methods:The chemical components of Jindan Tablets, Xiaoyan Lidan Tablets and ursodeoxycholic acid and their drug targets were collected from Traditional Chinese Medicine Database and Analysis Platform (TCMSP). DAVID 6.8 database was used to search for the associated diseases of the drug targets. The disease targets of gallstone and cholecystitis were collected from GeneCards and other databases. The protein-protein interactions network was established based on the intersecting targets of three drugs and two diseases. KEGG enrichment analysis was performed based on the DAVID 6.8 database. Cytoscape 3.7.1 software was used to construct a complex network and topology analysis of component- target- disease between three drugs and diseases.Results:222 chemical components and 3 133 drug targets were collected for Jindan Tablets. 104 chemical components and 1 425 action targets were collected for Xiaoyan Lidan Tablets. 1 chemical component and 119 action targets were collected for ursodeoxycholic acid. The three drugs were associated with 31 diseases. 1 382 disease targets for gallstones and cholecystitis were collected. There were 237, 163 and 33 targets for gallstones and cholecystitis in the three drugs, of which 17 were shared by the three drugs and 20 were shared by Jindan Tablets and Xiaoyan Lidan Tablets. Based on the DAVID database, 113, 74 and 10 significant KEGG enrichment pathways were obtained for the three drugs respectively.Conclusions:The three drugs shared many targets and pathways in the treatment of gallstones and cholecystitis, which all had the function of regulating metabolism and inhibiting inflammatory response, while participating in apoptosis, oxidative stress and cancer pathology process. However, they had their own special effects, with Jindan Tablets favoring involving in the cancer process and inhibition of inflammation, and promoting angiogenesis. Xiaoyan Lidan Tablets and ursodeoxycholic acid focused on regulating cholesterol metabolism, and Xiaoyan Lidan Tablets also regulated steroid metabolism and inhibit inflammation, while ursodeoxycholic acid regulated bile acid metabolism.

2.
Chinese Traditional Patent Medicine ; (12)1992.
Artículo en Chino | WPRIM | ID: wpr-574347

RESUMEN

AIM: To determine the contents of kaempferol and quercetinum in Jindan Tablet(Herba Lysimachiae,Rhizoma et Radix Polygoni Cuspidati,etc).by HPLC. METHODS: The determination was carried out with Symmertry C_(18) column.The mobile phase consisted of CH_3OH-0.4%H_3PO_4(50∶50) and the flow rate was 1 mL?min~(-1).The column temperature was at 25 ℃ and the detective wavelength was at 360 nm. RESULTS: The contents of kaempferol and quercetinum could be determined by HPLC.The linear concentration was in the range of 0.018-0.539 ?g for kaempferol and 0.005 38-0.161 4 ?g for quercetinum.The average recoveries were(94.0%) and 96.8%, respectively. CONCLUSION: The method is simple and accurate and can be used to control the quality of Jindan Tablet.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA